Here are five highlights:
1. The market will grow at a compound annual growth rate of 13.8 percent through 2025.
2. The adult stem cell sector captures the greatest market share, due to the cells ability to recreate trillions of specialized cells.
3. Currently, North America leads the market, because of investments, advanced technology and a rise in chronic disease cases. The region will likely hit $167.3 billion by 2025.
4. A key trend in the market is for stem cell companies to partner with pharmaceutical companies to increase revenue.
5. Key market players include STEMCELL Technologies, Astellas Pharma, Cellular Engineering Technologies, BioTime, Takara Bio, U.S. Stem Cell, BrainStorm Cell Therapeutics, Cytori Therapeutics, Osiris Therapeutics and Caladrius Biosciences.
More articles on biologics:
Global Stem Cells creates alliance with Aesthetic Polyclinic in Abu Dhabi — 5 points
Colorado Pain Care offering platelet rich plasma therapy — 3 points
Healing patients with their own bodies — The state of the regenerative medicine industry
